(Note: For PDF File Swipe To The End Of Article)
1. INTRODUCTION
Eclampsia is one of the most serious and life-threatening complications of pregnancy. It is an obstetric emergency characterized by the occurrence of new-onset generalized seizures in a pregnant or recently delivered woman, usually in association with preeclampsia. These seizures are not explained by another neurological or metabolic condition.
Eclampsia can occur during pregnancy, labor, or after childbirth. It is associated with severe maternal and fetal complications, including cerebral hemorrhage, pulmonary edema, kidney injury, placental abruption, fetal distress, premature delivery, and maternal death.
The condition is particularly dangerous because seizures may occur suddenly, sometimes without obvious warning symptoms. Therefore, early recognition of preeclampsia, appropriate antenatal monitoring, timely treatment, and rapid emergency intervention are essential.
Eclampsia is generally considered the neurological manifestation of severe preeclampsia. However, it is important to understand that seizures can occasionally occur in women who have not previously demonstrated significant hypertension or proteinuria.
The primary goals of treatment are:
- Protecting the mother from injury during seizures.
- Maintaining an adequate airway and oxygenation.
- Controlling and preventing recurrent seizures.
- Treating severe hypertension.
- Stabilizing the mother's condition.
- Assessing fetal well-being.
- Delivering the baby after maternal stabilization.
- Preventing maternal and neonatal complications.
Eclampsia requires immediate multidisciplinary management involving obstetricians, anesthesiologists, emergency physicians, nurses, midwives, and neonatal specialists.
2. DEFINITION OF ECLAMPSIA
Eclampsia is defined as the occurrence of new-onset generalized tonic-clonic seizures, or occasionally other seizure manifestations, in a woman with a hypertensive disorder of pregnancy, when the seizures cannot be attributed to another neurological or medical cause.
It most commonly develops in women with preeclampsia.
Eclampsia may occur:
- Before the onset of labor.
- During labor.
- After delivery.
- Within the first 48 hours postpartum most commonly, although later postpartum presentations can occur.
Unlike uncomplicated preeclampsia, eclampsia involves serious neurological complications and requires immediate emergency treatment.
Important distinction: Preeclampsia is a pregnancy-related hypertensive disorder characterized by hypertension and evidence of proteinuria or maternal organ dysfunction. Eclampsia is the occurrence of seizures in this clinical setting.
3. EPIDEMIOLOGY
Eclampsia occurs worldwide and remains an important contributor to maternal and perinatal morbidity and mortality.
Its frequency varies considerably between countries, healthcare systems, populations, and access to antenatal services.
The burden is generally higher in areas where:
- Antenatal care is inadequate.
- Blood pressure screening is inconsistent.
- Preeclampsia is recognized late.
- Emergency obstetric facilities are unavailable.
- Magnesium sulfate is not readily accessible.
- Referral systems are delayed.
- Maternal transportation to hospitals is difficult.
In well-resourced healthcare systems, routine antenatal screening and early treatment have reduced the frequency of severe complications.
In resource-limited settings, eclampsia continues to contribute significantly to maternal deaths.
3.1 Population at Risk
Eclampsia can affect pregnant women of different ages, socioeconomic backgrounds, and geographic locations.
However, certain groups have a higher risk of developing preeclampsia and its complications.
These include:
- Women experiencing their first pregnancy.
- Women with previous preeclampsia.
- Women with chronic hypertension.
- Women with kidney disease.
- Women with diabetes mellitus.
- Women with multiple pregnancies.
- Women with autoimmune disorders.
- Women with certain placental and vascular abnormalities.
3.2 Maternal and Fetal Burden
Eclampsia can produce serious consequences for both mother and baby.
Maternal consequences include:
- Cerebral hemorrhage.
- Aspiration pneumonia.
- Respiratory failure.
- Acute kidney injury.
- Disseminated intravascular coagulation.
- Placental abruption.
- Maternal death.
Fetal and neonatal consequences include:
- Prematurity.
- Intrauterine growth restriction.
- Fetal hypoxia.
- Low birth weight.
- Stillbirth.
- Neonatal complications related to premature delivery.
4. CLASSIFICATION OF ECLAMPSIA
Eclampsia can be classified according to the timing of seizure occurrence.
4.1 Antepartum Eclampsia
Antepartum eclampsia occurs before the onset of labor.
It can develop during the second half of pregnancy, most commonly after 20 weeks of gestation.
A pregnant woman may initially present with headache, visual disturbances, upper abdominal pain, or hypertension before developing a generalized seizure.
However, seizures can also occur unexpectedly.
4.2 Intrapartum Eclampsia
Intrapartum eclampsia occurs during labor.
It is particularly dangerous because the mother and fetus are exposed to the additional physiological stress of labor.
Management requires:
- Immediate seizure control.
- Maternal stabilization.
- Blood pressure management.
- Continuous or appropriate fetal monitoring.
- Assessment of labor progress.
- Planning for delivery.
4.3 Postpartum Eclampsia
Postpartum eclampsia occurs after childbirth.
It may develop during the first 48 hours after delivery or later during the postpartum period.
Some women develop postpartum eclampsia even when they did not experience obvious preeclampsia during pregnancy.
Symptoms may include:
- Severe headache.
- Blurred vision.
- Elevated blood pressure.
- Confusion.
- Seizures.
- Epigastric discomfort.
Postpartum eclampsia is especially important because women may have already left the hospital after delivery.
Any postpartum woman experiencing a seizure requires immediate emergency evaluation.
5. ETIOLOGY AND CAUSES
The exact mechanism responsible for eclampsia is not completely understood.
However, it is strongly associated with the abnormal placental development and maternal vascular dysfunction seen in preeclampsia.
The central problem involves abnormalities in placental blood flow, endothelial function, vascular regulation, and cerebral autoregulation.
5.1 Abnormal Placental Development
During normal pregnancy, specialized placental cells called trophoblasts invade the maternal uterine tissue.
They remodel the maternal spiral arteries, converting them into low-resistance vessels that provide adequate blood supply to the developing placenta.
In preeclampsia, this remodeling may be incomplete.
Consequently:
- Placental blood flow becomes inadequate.
- Placental oxygen supply may decrease.
- Oxidative stress increases.
- Placental signaling becomes abnormal.
- Antiangiogenic substances enter maternal circulation.
- Maternal endothelial dysfunction develops.
These changes contribute to the development of preeclampsia and increase the risk of eclampsia.
5.2 Endothelial Dysfunction
The vascular endothelium is the inner lining of blood vessels.
It normally regulates:
- Vascular tone.
- Blood pressure.
- Blood clotting.
- Vascular permeability.
- Inflammatory responses.
In preeclampsia, endothelial dysfunction causes abnormal vascular regulation.
This may result in:
- Vasoconstriction.
- Increased vascular resistance.
- Hypertension.
- Increased vascular permeability.
- Tissue edema.
- Abnormal coagulation.
Cerebral endothelial dysfunction plays an important role in the development of eclamptic seizures.
5.3 Cerebral Autoregulation Failure
The brain normally maintains relatively stable blood flow despite changes in systemic blood pressure.
This process is known as cerebral autoregulation.
In severe hypertensive disorders of pregnancy, autoregulation may become impaired.
Excessive blood pressure and endothelial injury can disrupt the blood-brain barrier.
Fluid may then move into brain tissue, producing vasogenic cerebral edema.
This contributes to neurological irritation and seizure activity.
5.4 Angiogenic Imbalance
Preeclampsia is associated with an imbalance between angiogenic and antiangiogenic factors.
Important substances include:
- Soluble fms-like tyrosine kinase-1 (sFlt-1).
- Placental growth factor (PlGF).
- Vascular endothelial growth factor (VEGF).
Increased antiangiogenic activity contributes to endothelial dysfunction and abnormal vascular responses.
These changes are associated with the development of preeclampsia and its severe complications.
6. PATHOPHYSIOLOGY OF ECLAMPSIA
Pathophysiology refers to the functional changes occurring in the body during a disease.
Understanding the pathophysiology of eclampsia helps explain why seizures occur and why urgent treatment is necessary.
The process generally begins with abnormal placental development.
Step 1: Abnormal Placental Implantation
In normal pregnancy, spiral arteries undergo extensive remodeling to supply sufficient blood to the placenta.
In preeclampsia, this remodeling may be incomplete.
The resulting uteroplacental circulation remains relatively high resistance.
Step 2: Reduced Placental Perfusion
Abnormal placental blood flow leads to placental ischemia and oxidative stress.
The stressed placenta releases substances that affect maternal vascular function.
Step 3: Maternal Endothelial Dysfunction
Placental factors cause widespread endothelial dysfunction.
Blood vessels become more prone to vasoconstriction, abnormal permeability, and disturbed coagulation.
Step 4: Development of Hypertension
Increased systemic vascular resistance contributes to elevated maternal blood pressure.
Severe hypertension increases the risk of cerebrovascular complications.
Step 5: Cerebral Vascular Disturbance
Cerebral autoregulation becomes impaired.
The blood-brain barrier may become disrupted, allowing fluid to accumulate within brain tissue.
This can produce cerebral edema.
Step 6: Neurological Irritation
Cerebral edema and vascular dysfunction interfere with normal neuronal activity.
The resulting neurological disturbance may trigger generalized seizures.
Step 7: Systemic Complications
During a generalized seizure:
- Oxygen consumption increases.
- Maternal oxygenation may become impaired.
- Aspiration may occur.
- Acidosis may develop.
- Fetal oxygen delivery may decrease.
- Maternal cardiovascular stress increases.
Repeated seizures can produce severe maternal and fetal injury.
7. RISK FACTORS
Several maternal, obstetric, medical, and placental factors increase the likelihood of developing preeclampsia and eclampsia.
7.1 Maternal Risk Factors
1. First Pregnancy
Women experiencing their first pregnancy have a higher risk of developing preeclampsia than women with a history of uncomplicated pregnancies.
2. Previous Preeclampsia
A previous history of preeclampsia increases the risk of recurrence in subsequent pregnancies.
The risk may be particularly high when previous disease was severe or occurred early in pregnancy.
3. Advanced Maternal Age
Pregnancy at an older maternal age is associated with an increased risk of hypertensive disorders.
4. Obesity
Obesity is associated with chronic inflammation, insulin resistance, and vascular abnormalities.
These factors increase the risk of preeclampsia.
5. Family History
A family history of preeclampsia in a mother or sister may increase an individual's susceptibility.
7.2 Medical Risk Factors
Important medical conditions include:
- Chronic hypertension.
- Chronic kidney disease.
- Pregestational diabetes mellitus.
- Systemic lupus erythematosus.
- Antiphospholipid syndrome.
- Certain cardiovascular disorders.
- Previous hypertensive pregnancy disorders.
7.3 Obstetric Risk Factors
Important obstetric factors include:
- Multiple pregnancy.
- Twin pregnancy.
- Triplet pregnancy.
- Certain placental disorders.
- Previous adverse pregnancy outcomes.
- Assisted reproductive conception in some risk groups.
7.4 Socioeconomic and Healthcare Factors
Inadequate healthcare access may increase the risk of severe complications.
Examples include:
- Lack of antenatal visits.
- Poor blood pressure monitoring.
- Delayed recognition of warning signs.
- Lack of laboratory investigations.
- Delayed hospital referral.
- Limited access to emergency obstetric services.
8. CLINICAL FEATURES OF ECLAMPSIA
Clinical manifestations may vary from one patient to another.
Some women experience warning symptoms before the first seizure, whereas others develop seizures without significant preceding complaints.
The most important clinical feature is a new-onset seizure in the setting of a pregnancy-related hypertensive disorder.
8.1 Warning Symptoms
Warning symptoms may include:
1. Severe Headache
A persistent or severe headache is an important neurological warning sign.
It may indicate cerebral vascular dysfunction or increased cerebral edema.
2. Visual Disturbances
Patients may complain of:
- Blurred vision.
- Flashing lights.
- Seeing spots.
- Double vision.
- Temporary visual loss.
These symptoms may occur because of disturbances in cerebral and retinal circulation.
3. Epigastric Pain
Pain in the upper central abdomen may indicate hepatic involvement.
It is an important warning sign in severe preeclampsia.
4. Right Upper Quadrant Pain
Pain beneath the right ribs may result from liver swelling or stretching of the hepatic capsule.
5. Nausea and Vomiting
Gastrointestinal symptoms may occur in severe preeclampsia.
6. Restlessness and Confusion
Some patients develop altered behavior, agitation, confusion, or reduced awareness.
7. Sudden Swelling
Swelling of the face and hands may occur, although edema alone is not diagnostic of preeclampsia.
8.2 Generalized Seizures
The typical eclamptic seizure is a generalized tonic-clonic seizure.
It may involve several stages.
A. Premonitory Stage
Some patients initially develop facial twitching or subtle changes in consciousness.
The eyes may deviate or become fixed.
B. Tonic Stage
During this stage:
- The muscles become rigid.
- The jaw may become tightly clenched.
- The body becomes stiff.
- Breathing may temporarily become ineffective.
- Cyanosis may occur.
This stage usually lasts a short time.
C. Clonic Stage
Repeated involuntary muscular contractions occur.
The arms, legs, and facial muscles may jerk rhythmically.
The patient may:
- Lose consciousness.
- Bite the tongue.
- Produce excessive saliva.
- Lose bladder control.
- Develop temporary respiratory compromise.
D. Postictal Stage
After the seizure, the patient may enter a period of unconsciousness or confusion.
Possible findings include:
- Drowsiness.
- Deep sleep.
- Confusion.
- Headache.
- Muscle soreness.
- Temporary neurological abnormalities.
Some women recover consciousness gradually, while others develop recurrent seizures.
8.3 Cardiovascular Features
Cardiovascular manifestations may include:
- Severe hypertension.
- Tachycardia.
- Increased vascular resistance.
- Cardiac strain.
- Arrhythmias in complicated cases.
8.4 Respiratory Features
Respiratory complications may include:
- Irregular breathing.
- Hypoxemia.
- Aspiration.
- Pulmonary edema.
- Respiratory failure.
8.5 Renal Features
Kidney involvement may produce:
- Reduced urine output.
- Oliguria.
- Increased serum creatinine.
- Acute kidney injury.
- Fluid retention.
8.6 Hepatic Features
Severe preeclampsia and eclampsia may be associated with:
- Elevated liver enzymes.
- Right upper quadrant pain.
- Hepatic dysfunction.
- Subcapsular liver hematoma.
- Rarely, hepatic rupture.
9. DIFFERENCE BETWEEN PREECLAMPSIA AND ECLAMPSIA
Preeclampsia and eclampsia are closely related conditions, but they are not identical.
Preeclampsia:
- Pregnancy-related hypertensive disorder.
- Usually develops after 20 weeks of gestation.
- Characterized by hypertension with proteinuria or maternal organ dysfunction.
- May involve headache and visual symptoms.
- Can affect the kidneys, liver, brain, and placenta.
- May progress to eclampsia.
Eclampsia:
- A severe neurological complication of pregnancy-related hypertension.
- Characterized by new-onset seizures.
- May occur before, during, or after delivery.
- Requires immediate emergency management.
- Carries a high risk of maternal and fetal complications.
10. DIAGNOSIS OF ECLAMPSIA
Eclampsia is primarily a clinical diagnosis.
A pregnant or postpartum woman who develops a new seizure in the setting of suspected preeclampsia should be treated as having eclampsia while alternative causes are assessed.
Treatment must not be delayed while waiting for laboratory results.
10.1 Clinical Assessment
The clinician should evaluate:
- Pregnancy status and gestational age.
- History of hypertension.
- Previous preeclampsia.
- Headache.
- Visual disturbances.
- Epigastric pain.
- Seizure characteristics.
- Consciousness level.
- Blood pressure.
- Respiratory status.
- Urine output.
10.2 Blood Pressure Measurement
Blood pressure measurement is essential.
Severe-range hypertension in pregnancy is generally defined as:
- Systolic blood pressure of 160 mmHg or higher.
- Diastolic blood pressure of 110 mmHg or higher.
Severe hypertension should be confirmed promptly and treated urgently.
10.3 Urine Protein Testing
Proteinuria may support the diagnosis of preeclampsia.
Methods include:
- Urine dipstick testing.
- Spot urine protein-to-creatinine ratio.
- Twenty-four-hour urine protein measurement.
However, the absence of proteinuria does not exclude preeclampsia when other diagnostic features are present.
10.4 Complete Blood Count
A complete blood count helps assess:
- Hemoglobin.
- Hematocrit.
- Platelet count.
- Evidence of hemolysis when combined with other tests.
Thrombocytopenia may indicate severe disease or HELLP syndrome.
10.5 Liver Function Tests
Liver investigations may include:
- Alanine aminotransferase.
- Aspartate aminotransferase.
- Bilirubin.
Elevated liver enzymes may indicate hepatic involvement.
10.6 Renal Function Tests
Important investigations include:
- Serum creatinine.
- Blood urea nitrogen.
- Serum electrolytes.
- Urine output monitoring.
These tests help identify acute kidney injury.
10.7 Coagulation Profile
Coagulation investigations may include:
- Prothrombin time.
- Activated partial thromboplastin time.
- Fibrinogen.
They are particularly important when disseminated intravascular coagulation or placental abruption is suspected.
10.8 Additional Investigations
Depending on the clinical condition, investigations may include:
- Lactate dehydrogenase.
- Peripheral blood smear.
- Blood glucose.
- Arterial or venous blood gas.
- Electrocardiography.
- Chest radiography.
- Neuroimaging.
11. DIFFERENTIAL DIAGNOSIS
Not every seizure during pregnancy is caused by eclampsia.
Other conditions must be considered.
11.1 Epilepsy
A patient with a previous history of epilepsy may experience a seizure during pregnancy.
A detailed medical history and medication review are important.
11.2 Cerebral Hemorrhage
Intracranial bleeding may cause sudden headache, neurological deterioration, and seizures.
11.3 Cerebral Venous Sinus Thrombosis
Pregnancy and the postpartum period increase the risk of venous thrombosis.
Cerebral venous sinus thrombosis can produce headache, seizures, and focal neurological signs.
11.4 Meningitis and Encephalitis
Central nervous system infections may cause:
- Fever.
- Headache.
- Neck stiffness.
- Altered consciousness.
- Seizures.
11.5 Hypoglycemia
Severe hypoglycemia can cause altered consciousness and seizures.
Blood glucose should be checked promptly.
11.6 Electrolyte Disturbances
Abnormal sodium, calcium, and other electrolyte levels may contribute to seizure activity.
11.7 Brain Tumors and Other Neurological Disorders
Intracranial tumors and structural abnormalities may cause new-onset seizures.
11.8 Posterior Reversible Encephalopathy Syndrome
Posterior reversible encephalopathy syndrome (PRES) is an important neurological condition associated with eclampsia and severe hypertension.
It may produce:
- Headache.
- Seizures.
- Visual disturbances.
- Altered mental status.
- Cerebral edema, often involving posterior brain regions.
Magnetic resonance imaging may help confirm the diagnosis.
12. MANAGEMENT OF ECLAMPSIA
Eclampsia is an obstetric emergency.
Management should begin immediately when the condition is suspected.
The priority is maternal stabilization, not immediate delivery during an active seizure.
The major treatment objectives are:
- Maintain airway patency.
- Ensure adequate breathing and oxygenation.
- Support circulation.
- Stop the seizure.
- Prevent recurrent seizures.
- Control severe hypertension.
- Monitor maternal organ function.
- Assess fetal well-being.
- Plan delivery after maternal stabilization.
12.1 Immediate Emergency Management
When a seizure occurs, the healthcare team should act rapidly.
Step 1: Call for Emergency Assistance
Immediately activate the obstetric emergency response team.
Request assistance from:
- Obstetricians.
- Anesthesiologists.
- Emergency physicians.
- Nurses.
- Neonatal specialists.
Step 2: Protect the Patient
Place the patient in a safe position.
Important measures include:
- Protecting her from nearby objects.
- Preventing falls.
- Supporting the head.
- Avoiding unnecessary restraint.
- Avoiding attempts to forcefully open the jaw.
Never place objects or fingers inside the patient's mouth during a seizure.
Step 3: Position the Patient
Place the patient in a lateral position, preferably left lateral when feasible.
This helps reduce aspiration risk and may improve venous return.
Step 4: Maintain the Airway
Assess airway patency.
Suction secretions when necessary and when it can be performed safely.
Provide airway support if required.
Step 5: Provide Oxygen
Administer oxygen when the patient is hypoxemic or experiencing respiratory compromise.
Monitor oxygen saturation.
Step 6: Establish Intravenous Access
Establish appropriate intravenous access.
Blood samples should be obtained for laboratory investigations without delaying emergency treatment.
Step 7: Monitor Vital Signs
Closely monitor:
- Blood pressure.
- Heart rate.
- Respiratory rate.
- Oxygen saturation.
- Consciousness level.
- Urine output.
Step 8: Administer Magnesium Sulfate
Magnesium sulfate is the first-line medication for treating and preventing eclamptic seizures.
It should be administered according to an established hospital protocol.
13. MAGNESIUM SULFATE THERAPY
Magnesium sulfate is the standard first-line anticonvulsant treatment for eclampsia.
It reduces the risk of recurrent seizures and is more effective than several alternative anticonvulsants in this setting.
It should also be used for seizure prophylaxis in appropriate patients with severe preeclampsia.
13.1 Mechanism of Action
The exact mechanism by which magnesium sulfate prevents eclamptic seizures is not completely understood.
Its proposed actions include:
- Reducing neuronal excitability.
- Modulating calcium-dependent processes.
- Influencing neurotransmitter activity.
- Producing cerebral vascular effects.
- Stabilizing abnormal neuromuscular activity.
These actions help reduce seizure activity.
13.2 Loading Dose
A commonly used intravenous regimen is:
- Magnesium sulfate 4–6 grams intravenously over approximately 20–30 minutes.
Some established protocols use different doses or administration times.
13.3 Maintenance Dose
After the loading dose, a commonly used maintenance regimen is:
- Magnesium sulfate 1–2 grams per hour by intravenous infusion.
Treatment is generally continued for 24 hours after delivery or 24 hours after the last seizure, whichever is later, according to the applicable protocol.
13.4 Alternative Intramuscular Regimen
Where continuous intravenous infusion is not feasible, an accepted intramuscular regimen may be used.
A commonly used Pritchard regimen includes:
- 4 grams intravenously as a loading dose.
- 10 grams intramuscularly, divided between the two buttocks.
- 5 grams intramuscularly every four hours, alternating buttocks, when safety criteria are met.
The precise regimen must follow local obstetric guidelines and trained clinical supervision.
13.5 Monitoring During Magnesium Therapy
Magnesium sulfate can produce toxicity, particularly when renal function is impaired.
Monitor:
- Respiratory rate.
- Deep tendon reflexes.
- Urine output.
- Level of consciousness.
- Oxygen saturation.
- Renal function when indicated.
Before administering a repeat intramuscular dose, the healthcare professional should confirm that the required safety criteria are satisfied.
Important warning signs of toxicity include:
- Loss of deep tendon reflexes.
- Respiratory depression.
- Severe muscle weakness.
- Reduced consciousness.
- Cardiac conduction abnormalities.
- Cardiac arrest in severe toxicity.
13.6 Antidote for Magnesium Toxicity
The antidote for clinically significant magnesium toxicity is calcium gluconate.
A commonly used emergency dose is:
- Calcium gluconate 1 gram intravenously, usually given as 10 mL of a 10% solution slowly over approximately 10 minutes.
Administration requires appropriate monitoring and clinical supervision.
Additional management includes stopping magnesium sulfate and supporting respiratory and cardiovascular function.
14. MANAGEMENT OF RECURRENT SEIZURES
Some patients may develop recurrent seizures despite receiving magnesium sulfate.
In these cases, the healthcare team should:
- Reassess the airway.
- Check oxygenation.
- Confirm magnesium administration and dosing.
- Assess for magnesium toxicity.
- Consider an additional magnesium sulfate bolus according to protocol.
- Seek urgent anesthetic and critical care support.
- Evaluate alternative neurological causes.
Persistent seizures may require additional anticonvulsant therapy, such as benzodiazepines, under specialist supervision.
Refractory seizures may require advanced airway management, intubation, and intensive care.
15. MANAGEMENT OF SEVERE HYPERTENSION
Severe hypertension increases the risk of maternal stroke and other cerebrovascular complications.
Therefore, persistent severe-range blood pressure requires urgent treatment.
The objective is to reduce blood pressure safely without causing excessive reduction in uteroplacental perfusion.
Commonly used medications include:
15.1 Intravenous Labetalol
Labetalol is a combined alpha- and beta-adrenergic blocker.
It reduces blood pressure by decreasing peripheral vascular resistance and cardiac sympathetic activity.
It is commonly used for acute severe hypertension in pregnancy.
15.2 Intravenous Hydralazine
Hydralazine is a direct arterial vasodilator.
It decreases systemic vascular resistance and helps reduce blood pressure.
It is another established option for acute severe hypertension.
15.3 Immediate-Release Oral Nifedipine
Oral immediate-release nifedipine may be used when intravenous access is unavailable or when specified by the treatment protocol.
It is a calcium-channel blocker that relaxes vascular smooth muscle.
Important Treatment Principle
Antihypertensive therapy and magnesium sulfate have different purposes.
- Magnesium sulfate prevents and treats seizures.
- Antihypertensive drugs reduce dangerously elevated blood pressure.
One medication does not replace the other.
16. FLUID MANAGEMENT
Fluid management is an important part of eclampsia treatment.
Patients with severe preeclampsia may have abnormal endothelial permeability and reduced intravascular volume despite tissue edema.
Excessive intravenous fluid administration can lead to pulmonary edema.
Therefore:
- Avoid unnecessary fluid boluses.
- Monitor fluid intake.
- Record urine output.
- Assess respiratory status.
- Monitor signs of pulmonary edema.
- Individualize intravenous fluid administration.
- Consider renal function and ongoing losses.
Urinary catheterization may be appropriate for accurate urine output measurement in critically ill patients.
17. DEFINITIVE TREATMENT: DELIVERY OF THE BABY
Delivery is the definitive treatment for the underlying pregnancy-related placental disorder.
However, delivery should generally occur after initial maternal stabilization.
An active seizure is not the time to attempt immediate operative delivery without first addressing airway, breathing, circulation, and seizure control.
The timing and mode of delivery depend on:
- Maternal clinical condition.
- Gestational age.
- Fetal condition.
- Cervical examination.
- Labor progress.
- Obstetric history.
- Availability of appropriate facilities.
17.1 Vaginal Delivery
Vaginal delivery may be appropriate when:
- The mother is stabilized.
- There is no immediate obstetric indication for cesarean delivery.
- The fetus is in a suitable condition.
- Labor can be safely induced or continued.
Induction of labor may be considered according to maternal and fetal circumstances.
17.2 Cesarean Section
Cesarean delivery may be necessary when:
- There is fetal distress requiring urgent delivery.
- There are other obstetric indications.
- Vaginal delivery is not expected to occur safely within an appropriate timeframe.
- Maternal or fetal circumstances make operative delivery preferable.
Eclampsia alone does not automatically mean that cesarean section is required.
17.3 Anesthetic Considerations
Anesthetic management requires careful assessment.
Important considerations include:
- Platelet count.
- Coagulation status.
- Airway assessment.
- Blood pressure control.
- Magnesium sulfate administration.
- Pulmonary status.
- Neurological condition.
The anesthesiology team should be involved early in severe cases.
18. POSTPARTUM MANAGEMENT
The risk of complications does not end immediately after childbirth.
Patients with eclampsia require continued monitoring during the postpartum period.
Important measures include:
- Continuing magnesium sulfate according to protocol.
- Monitoring blood pressure.
- Assessing consciousness.
- Monitoring respiratory function.
- Measuring urine output.
- Checking renal and liver function.
- Assessing platelet count.
- Monitoring for pulmonary edema.
- Evaluating recurrent headaches and visual symptoms.
Postpartum hypertension may persist or worsen after delivery.
Some patients require ongoing antihypertensive treatment.
18.1 Delayed Postpartum Eclampsia
Delayed postpartum eclampsia may develop after the patient has been discharged.
Symptoms requiring urgent assessment include:
- Severe headache.
- Visual disturbances.
- New seizure.
- Confusion.
- Severe upper abdominal pain.
- Shortness of breath.
- Markedly elevated blood pressure.
Women should receive clear discharge instructions about these warning symptoms.
19. COMPLICATIONS OF ECLAMPSIA
Eclampsia can produce life-threatening maternal and fetal complications.
19.1 Maternal Complications
1. Cerebral Hemorrhage
Severe hypertension may cause rupture of cerebral blood vessels.
This can result in intracranial bleeding, permanent neurological injury, or death.
2. Cerebral Edema
Abnormal cerebral vascular regulation can cause fluid accumulation within brain tissue.
This may contribute to seizures and altered consciousness.
3. Aspiration Pneumonia
During a seizure, stomach contents may enter the respiratory tract.
This can cause chemical pneumonitis or aspiration pneumonia.
4. Pulmonary Edema
Fluid accumulates within lung tissue and alveoli.
Clinical features include:
- Severe breathlessness.
- Hypoxemia.
- Crackles on auscultation.
- Increased respiratory rate.
5. Acute Kidney Injury
Reduced renal perfusion and endothelial injury may impair kidney function.
6. HELLP Syndrome
HELLP syndrome is a severe pregnancy-related complication characterized by:
- Hemolysis.
- Elevated liver enzymes.
- Low platelet count.
It may coexist with severe preeclampsia and eclampsia.
7. Disseminated Intravascular Coagulation
Abnormal activation of the coagulation system can cause widespread clot formation followed by consumption of clotting factors and bleeding.
8. Placental Abruption
Premature separation of the placenta from the uterine wall may cause:
- Vaginal bleeding.
- Abdominal pain.
- Uterine tenderness.
- Fetal distress.
- Maternal shock.
9. Liver Hematoma or Rupture
Severe hepatic involvement may cause a subcapsular hematoma.
Rarely, liver rupture can occur and produce life-threatening internal bleeding.
10. Maternal Death
Without timely treatment, eclampsia can cause fatal complications.
19.2 Fetal and Neonatal Complications
1. Premature Birth
Early delivery may be necessary to protect the mother.
This increases the likelihood of neonatal complications associated with prematurity.
2. Intrauterine Growth Restriction
Placental insufficiency can reduce the supply of oxygen and nutrients to the fetus.
This may impair fetal growth.
3. Fetal Hypoxia
Maternal hypoxemia, placental abruption, or severe uteroplacental dysfunction can reduce fetal oxygen delivery.
4. Fetal Distress
The fetus may develop abnormal heart rate patterns.
5. Low Birth Weight
Premature delivery and restricted fetal growth can contribute to low birth weight.
6. Stillbirth
Severe placental complications and maternal instability may lead to fetal death.
7. Neonatal Respiratory Problems
Premature infants may develop respiratory distress syndrome and require neonatal intensive care.
20. PREVENTION OF ECLAMPSIA
Prevention focuses primarily on identifying and treating preeclampsia before seizures develop.
20.1 Regular Antenatal Care
Antenatal visits allow healthcare professionals to identify early signs of hypertensive disorders.
Routine assessment includes:
- Blood pressure measurement.
- Assessment of symptoms.
- Urine protein testing when indicated.
- Maternal risk assessment.
- Fetal growth assessment when indicated.
20.2 Risk Assessment
Women with significant risk factors should receive appropriate preventive care.
Risk factors include:
- Previous preeclampsia.
- Chronic hypertension.
- Kidney disease.
- Diabetes mellitus.
- Autoimmune disease.
- Multiple pregnancy.
20.3 Low-Dose Aspirin
Low-dose aspirin is recommended for selected pregnant women at increased risk of preeclampsia.
Depending on the guideline, treatment is generally started between 12 and 28 weeks, ideally before 16 weeks.
The exact dose and eligibility criteria should follow local guidelines.
Aspirin should not be started independently without appropriate clinical assessment.
20.4 Calcium Supplementation
Calcium supplementation may reduce the risk of preeclampsia in populations with low dietary calcium intake.
The appropriate dose depends on dietary intake and applicable guidelines.
20.5 Early Recognition of Warning Symptoms
Pregnant women should be educated to seek immediate medical attention if they develop:
- Severe headache.
- Blurred vision.
- Severe upper abdominal pain.
- Sudden breathlessness.
- Convulsions.
- Markedly elevated blood pressure.
- Other concerning symptoms.
20.6 Timely Management of Preeclampsia
Women diagnosed with preeclampsia require appropriate monitoring and treatment.
Magnesium sulfate is used for seizure prevention in patients with severe features when indicated.
Blood pressure must be controlled when severe-range values occur.
Timely delivery should be planned according to maternal and fetal condition.
21. NURSING MANAGEMENT OF ECLAMPSIA
Nursing care is extremely important in the management of eclampsia.
Nurses play a central role in early recognition, emergency response, medication administration, monitoring, prevention of injury, and patient education.
21.1 Initial Nursing Assessment
The nurse should assess:
- Level of consciousness.
- Blood pressure.
- Pulse rate.
- Respiratory rate.
- Oxygen saturation.
- Temperature.
- Seizure activity.
- Headache.
- Visual disturbances.
- Epigastric pain.
- Urine output.
21.2 Nursing Interventions During a Seizure
Important interventions include:
- Call for immediate assistance.
- Stay with the patient.
- Protect the patient from injury.
- Position the patient laterally when feasible.
- Protect the head.
- Do not restrain the limbs.
- Do not place objects in the mouth.
- Maintain airway patency.
- Provide oxygen when indicated.
- Suction secretions when appropriate and safe.
- Observe and document seizure duration.
- Monitor oxygen saturation and vital signs.
- Prepare prescribed emergency medications.
21.3 Nursing Care After a Seizure
Following the seizure:
- Assess airway and breathing.
- Check oxygen saturation.
- Assess consciousness.
- Reassess blood pressure.
- Check for injuries.
- Evaluate fetal status.
- Record seizure characteristics.
- Administer prescribed magnesium sulfate.
- Prepare for further emergency treatment.
21.4 Monitoring Magnesium Sulfate
The nurse must monitor the patient for magnesium toxicity.
Important observations include:
- Respiratory rate.
- Deep tendon reflexes.
- Urine output.
- Level of consciousness.
- Oxygen saturation.
The nurse should immediately report absent reflexes, respiratory depression, severe weakness, or reduced urine output.
Calcium gluconate should be available according to institutional protocol.
21.5 Blood Pressure Monitoring
Blood pressure should be checked frequently according to the severity of the condition and treatment protocol.
The nurse should promptly report severe-range blood pressure.
Prescribed antihypertensive drugs should be administered with appropriate monitoring.
21.6 Fluid Balance
Accurate intake and output monitoring is essential.
The nurse should:
- Record all intravenous fluids.
- Monitor urine output.
- Observe for edema.
- Assess breathing.
- Watch for pulmonary edema.
- Avoid unprescribed fluid administration.
21.7 Psychological Support
Eclampsia is frightening for patients and families.
The nursing team should:
- Explain the condition in simple language.
- Provide reassurance.
- Maintain privacy and dignity.
- Involve family members when appropriate.
- Explain the purpose of medications.
- Offer postpartum support.
21.8 Documentation
Accurate documentation should include:
- Time of seizure onset.
- Duration of seizure.
- Seizure characteristics.
- Vital signs.
- Oxygen saturation.
- Medication doses and administration times.
- Urine output.
- Neurological assessment.
- Fetal assessment.
- Response to treatment.
- Communication with the medical team.
22. IMPORTANT NURSING DIAGNOSES
Possible nursing diagnoses include:
- Risk for injury related to seizure activity.
- Ineffective airway clearance related to reduced consciousness.
- Risk for aspiration related to seizure activity.
- Impaired gas exchange related to respiratory compromise.
- Risk for decreased cardiac output related to severe hypertension and cardiovascular stress.
- Excess fluid volume related to abnormal fluid regulation.
- Acute pain related to headache and physiological stress.
- Anxiety related to emergency hospitalization.
- Deficient knowledge related to the disease and preventive care.
- Risk for impaired maternal-fetal dyad related to maternal and placental complications.
23. MATERNAL MONITORING
Maternal monitoring should continue throughout the acute phase and postpartum period.
Important monitoring parameters include:
| Parameter | Purpose |
|---|---|
| Blood pressure | Detect severe hypertension |
| Respiratory rate | Identify respiratory depression |
| Oxygen saturation | Assess oxygenation |
| Pulse rate | Evaluate cardiovascular status |
| Deep tendon reflexes | Monitor magnesium toxicity |
| Urine output | Assess renal function |
| Consciousness | Identify neurological deterioration |
| Platelet count | Detect thrombocytopenia |
| Liver enzymes | Assess hepatic involvement |
| Serum creatinine | Assess renal impairment |
| Fluid balance | Prevent fluid overload |
24. FETAL MONITORING
Fetal assessment is essential because maternal seizures and placental dysfunction can affect fetal oxygen delivery.
Assessment may include:
- Fetal heart rate monitoring.
- Cardiotocography.
- Ultrasound assessment.
- Fetal growth assessment.
- Amniotic fluid assessment.
- Doppler studies when indicated.
During a maternal seizure, transient fetal bradycardia may occur.
Fetal heart rate abnormalities should be reassessed after maternal stabilization because they may improve when maternal oxygenation and circulation are restored.
Persistent fetal compromise requires obstetric evaluation and appropriate intervention.
25. ECLAMPSIA AND HELLP SYNDROME
HELLP syndrome is a serious complication associated with preeclampsia.
The term HELLP represents:
- H: Hemolysis.
- EL: Elevated liver enzymes.
- LP: Low platelet count.
It may occur with or without eclampsia.
Clinical Features
Patients may experience:
- Right upper quadrant pain.
- Epigastric pain.
- Nausea.
- Vomiting.
- Headache.
- Malaise.
- Hypertension.
Diagnosis
Investigations may show:
- Hemolytic anemia.
- Elevated AST and ALT.
- Reduced platelet count.
- Increased lactate dehydrogenase.
Management
Management includes maternal stabilization, blood pressure control, seizure prevention when indicated, correction of complications, and delivery planning.
26. ECLAMPSIA AND POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
Posterior reversible encephalopathy syndrome is an important neurological complication associated with eclampsia.
It is characterized by vasogenic edema, often affecting the posterior regions of the brain.
Symptoms
- Headache.
- Seizures.
- Visual abnormalities.
- Confusion.
- Altered consciousness.
Diagnosis
Magnetic resonance imaging is particularly useful.
Management
Management focuses on:
- Controlling blood pressure.
- Treating seizures.
- Stabilizing the patient.
- Managing the underlying obstetric condition.
- Delivering when appropriate.
27. DIFFERENCES BETWEEN ECLAMPTIC AND EPILEPTIC SEIZURES
Although both conditions involve seizure activity, their causes and management differ.
Eclamptic seizures:
- Associated with pregnancy-related hypertensive disorders.
- Often occur after 20 weeks of pregnancy or postpartum.
- Frequently associated with severe preeclampsia.
- Magnesium sulfate is the preferred first-line anticonvulsant.
- Delivery is required after maternal stabilization.
Epileptic seizures:
- Caused by an underlying seizure disorder or other neurological condition.
- May occur before, during, or after pregnancy.
- Managed according to the specific epilepsy diagnosis.
- Antiseizure medication is selected according to pregnancy safety and clinical circumstances.
- Delivery is not automatically required because of a seizure.
28. PROGNOSIS
The prognosis of eclampsia depends on several factors.
These include:
- Speed of diagnosis.
- Availability of emergency obstetric care.
- Timely administration of magnesium sulfate.
- Control of severe hypertension.
- Severity of neurological complications.
- Kidney and liver function.
- Gestational age.
- Fetal condition.
- Presence of associated HELLP syndrome or placental abruption.
With prompt and appropriate management, many women recover without permanent neurological injury.
However, severe cases may result in long-term maternal complications or death.
The fetus may also experience complications associated with placental insufficiency and premature delivery.
29. LONG-TERM EFFECTS AFTER ECLAMPSIA
Women who experience preeclampsia or eclampsia have an increased risk of certain long-term health problems.
These include:
- Chronic hypertension.
- Cardiovascular disease.
- Stroke.
- Ischemic heart disease.
- Chronic kidney disease in some patients.
- Recurrence of hypertensive disorders in future pregnancies.
Long-term follow-up is therefore important.
Patients should receive counseling about:
- Blood pressure monitoring.
- Healthy nutrition.
- Regular physical activity.
- Weight management.
- Diabetes screening when appropriate.
- Cardiovascular risk assessment.
- Planning future pregnancies.
30. PREVENTION OF RECURRENCE IN FUTURE PREGNANCIES
Women with a history of eclampsia require early antenatal assessment in subsequent pregnancies.
Important preventive measures include:
- Preconception counseling.
- Review of previous pregnancy records.
- Assessment of chronic hypertension.
- Evaluation of kidney function when indicated.
- Early antenatal booking.
- Assessment for low-dose aspirin eligibility.
- Calcium supplementation when appropriate.
- Regular blood pressure monitoring.
- Fetal growth surveillance when indicated.
- Clear education regarding warning symptoms.
A previous history of eclampsia does not mean that recurrence is inevitable.
Appropriate preventive care can reduce risk and improve pregnancy outcomes.
31. PATIENT EDUCATION
Patient education is an essential component of prevention and long-term management.
Pregnant women should understand that severe headache, visual disturbances, upper abdominal pain, and seizures are not normal pregnancy symptoms.
They should be encouraged to attend regular antenatal appointments.
Patients should be instructed to seek emergency medical attention if they develop:
- Severe or persistent headache.
- Blurred vision.
- Sudden visual loss.
- Severe upper abdominal pain.
- Difficulty breathing.
- Convulsions.
- Confusion.
- Other severe or unusual symptoms.
Women discharged after an episode of eclampsia should receive a clear postpartum follow-up plan.
32. IMPORTANT MEDICATIONS USED IN ECLAMPSIA
The following medications may be used in the management of eclampsia, depending on the clinical situation.
1. Magnesium Sulfate
Purpose: First-line medication for seizure treatment and prevention.
2. Labetalol
Purpose: Treatment of acute severe hypertension.
3. Hydralazine
Purpose: Treatment of acute severe hypertension.
4. Nifedipine
Purpose: Blood pressure control in selected patients.
5. Calcium Gluconate
Purpose: Antidote for clinically significant magnesium toxicity.
6. Benzodiazepines
Purpose: May be used for persistent or refractory seizures under specialist supervision.
7. Corticosteroids
Purpose: Antenatal corticosteroids may be administered when indicated to improve fetal lung maturation in pregnancies at risk of premature delivery. They are not a treatment for eclamptic seizures.
33. DIFFERENCE BETWEEN MAGNESIUM SULFATE AND ANTIHYPERTENSIVE DRUGS
This distinction is extremely important for examinations and clinical practice.
| Magnesium sulfate | Antihypertensive drugs |
|---|---|
| Prevents and treats seizures | Reduce elevated blood pressure |
| Acts on neurological excitability | Act on cardiovascular and vascular mechanisms |
| First-line anticonvulsant in eclampsia | Used for severe hypertension |
| Requires toxicity monitoring | Requires blood pressure monitoring |
| Calcium gluconate is its antidote | Antidote depends on the specific drug |
Magnesium sulfate does not replace antihypertensive treatment.
Similarly, antihypertensive drugs do not replace magnesium sulfate for seizure control.
34. EMERGENCY MANAGEMENT SUMMARY
The emergency approach to eclampsia can be remembered in the following sequence:
A — Airway
Maintain airway patency and protect against aspiration.
B — Breathing
Assess respiratory function and provide oxygen when indicated.
C — Circulation
Establish intravenous access and monitor circulation.
D — Drugs
Administer magnesium sulfate and appropriate antihypertensive treatment.
E — Evaluation
Assess maternal condition, laboratory findings, and fetal well-being.
F — Further management
Plan delivery after maternal stabilization and continue postpartum monitoring.
35. COMMON MYTHS ABOUT ECLAMPSIA
Myth 1: Eclampsia only occurs during labor.
Fact: It can occur before labor, during labor, or after delivery.
Myth 2: Every patient with eclampsia has proteinuria.
Fact: Proteinuria may be absent in some women with preeclampsia and eclampsia.
Myth 3: Magnesium sulfate is used primarily to reduce blood pressure.
Fact: Magnesium sulfate is primarily used to prevent and treat seizures.
Myth 4: Cesarean section is always necessary.
Fact: The mode of delivery depends on maternal and fetal conditions and obstetric indications.
Myth 5: Eclampsia cannot occur after childbirth.
Fact: Postpartum eclampsia is a recognized and potentially life-threatening condition.
Myth 6: Delivery immediately stops all complications.
Fact: Maternal complications may persist or develop after delivery, so continued monitoring is essential.
36. IMPORTANT EXAMINATION POINTS
The following facts are particularly important for medical and nursing examinations.
- Eclampsia is characterized by seizures associated with a pregnancy-related hypertensive disorder.
- It can occur antepartum, intrapartum, or postpartum.
- Preeclampsia is the major underlying clinical condition.
- Severe headache and visual disturbances are important warning symptoms.
- Magnesium sulfate is the first-line anticonvulsant.
- Severe hypertension requires urgent antihypertensive treatment.
- Labetalol, hydralazine, and nifedipine are commonly used antihypertensive agents.
- Calcium gluconate is the antidote for magnesium toxicity.
- Absent deep tendon reflexes may indicate magnesium toxicity.
- Reduced respiratory rate is a serious warning sign.
- Maternal stabilization comes before delivery.
- Delivery is the definitive treatment for the underlying placental disorder.
- Cesarean section is not automatically required.
- Pulmonary edema is an important maternal complication.
- HELLP syndrome may coexist with eclampsia.
- Postpartum eclampsia can occur after hospital discharge.
- Long-term cardiovascular follow-up is important.
37. CONCLUSION
Eclampsia is a life-threatening obstetric emergency characterized by new-onset seizures in association with a hypertensive disorder of pregnancy. It represents one of the most severe complications of preeclampsia and requires immediate recognition and effective multidisciplinary management.
The disease is associated with abnormal placental development, endothelial dysfunction, hypertension, cerebral vascular disturbance, and neurological complications.
Early warning symptoms may include severe headache, visual disturbances, epigastric pain, and altered consciousness. However, seizures can occur without obvious warning signs.
The cornerstone of emergency management is maternal stabilization, airway protection, magnesium sulfate administration, treatment of severe hypertension, careful fluid management, and appropriate fetal assessment.
Delivery is the definitive treatment for the underlying placental disorder, but it should generally be undertaken after initial maternal stabilization.
Nurses and other healthcare professionals play a vital role in recognizing warning symptoms, preventing injury, monitoring magnesium sulfate therapy, identifying complications, and educating patients.
With timely diagnosis, appropriate emergency treatment, skilled obstetric care, and regular postpartum follow-up, many maternal and neonatal complications can be prevented or reduced.
The most important clinical principle is simple: recognize eclampsia early, control seizures promptly, stabilize the mother, control severe blood pressure, and arrange appropriate delivery.
38. REFERENCES AND RECOMMENDED READING
For further medical study and clinical guidance, consult:
- World Health Organization (WHO) — Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia.
- American College of Obstetricians and Gynecologists (ACOG) — Practice Bulletin: Gestational Hypertension and Preeclampsia.
- National Institute for Health and Care Excellence (NICE) — Hypertension in Pregnancy: Diagnosis and Management.
- Williams Obstetrics — Hypertensive Disorders of Pregnancy.
- Gabbe's Obstetrics — Normal and Problem Pregnancies.
- Current institutional obstetric emergency protocols and magnesium sulfate treatment guidelines.
.jpeg)
